In summary, our data demonstrate the reliance upon HIFs and HIF-induced autophagy for survival in aggressive colorectal cancers and indicate that inhibition of HIF-2α, alone or in combination with chemotherapeutic drugs, constitutes a promising strategy to succeed in overcome resistance to cancer treatment. This evidence concerns the gene EPAS1 and colorectal cancer.